Low Molecular Weight Heparin Market Scope And Analysis

  • Report Code : TIPRE00026174
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 191
Buy Now

Low Molecular Weight Heparin Market Scope, Growth, Size and Share by 2028

Buy Now

Low Molecular Weight Heparin Market Report Low Molecular Weight Heparin Market Size and Share Low Molecular Weight Heparin Market Scope and Analysis

Low Molecular Weight Heparin Market Report Scope

Report Attribute Details
Market size in 2021 US$ 3.66 Billion
Market Size by 2028 US$ 5.73 Billion
Global CAGR (2021 - 2028) 6.6%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product Type
  • Enoxaparin
  • Dalteparin
  • Tinzaparin
  • Fraxiparine
  • Nadroparin
By Packaging
  • Multi-Vials and Prefilled Syringes
By Application
  • Deep Vein Thrombosis
  • Acute Coronary Syndrome
  • Pulmonary Embolism
By End User
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Aspen Holdings
  • Changzhou Qianhong Bio pharma
  • LEOPHARMA A S
  • Teva Pharmaceutical Industries Ltd
  • B Braun Medical Inc
  • Pfizer Inc
  • Sanofi Aventis
  • Dr Reddy s Laboratories Limited
  • Abbott

    • COVID Impacts

    The spread of the COVID-19 pandemic has emphasized health data sharing and interoperability under the microscope. The infection of novel coronavirus in children is mild compared to adults, and children are assigned a better prognosis. The interruptions in the supply chain and the massive demand for efficient treatments for COVID-19 have put the health research industry in Asia-Pacific in a crucial position.

    Company Profiles

    • Aspen Holdings
    • Changzhou Qianhong Bio-Pharma
    • Leopharma A/S
    • Teva Pharmaceutical Industries Ltd.
    • B. Braun Medical, Inc.
    • Pfizer, Inc.
    • Sanofi
    • Dr. Reddy's Laboratories Limited
    • Abbott
    • Novartis AG